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Polyglycylation is a posttranslational modification
that generates glycine side chains on proteins. Here
we identify a family of evolutionarily conserved
glycine ligases that modify tubulin using different
enzymatic mechanisms. In mammals, two distinct
enzyme types catalyze the initiation and elongation
steps of polyglycylation, whereas Drosophila glycy-
lases are bifunctional. We further show that the
human elongating glycylase has lost enzymatic
activity due to two amino acid changes, suggesting
that the functions of protein glycylation could be
sufficiently fulfilled by monoglycylation. Depletion of
a glycylase in Drosophila using RNA interference
results in adult flies with strongly decreased total gly-
cylation levels and male sterility associated with de-
fects in sperm individualization and axonemal main-
tenance. A more severe RNAi depletion is lethal at
early developmental stages, indicating that protein
glycylation is essential. Together with the observa-
tion that multiple proteins are glycylated, our func-
tional data point towards a general role of glycylation
in protein functions.
INTRODUCTION
Polyglycylation is a posttranslational modification that generates
side chains of glycine on the g-carboxyl groups of specific gluta-
mate residues of target proteins (Bre´ et al., 1998; Vinh et al.,
1999). Similarly to polyglutamylation (Edde´ et al., 1990), this
posttranslational modification was discovered on tubulin, where
it occurs within the carboxy-terminal tail domains (Redeker et al.,
1994). While polyglutamylation was observed on many different
types of microtubules (MTs), polyglycylation is particularly1076 Cell 137, 1076–1087, June 12, 2009 ª2009 Elsevier Inc.prominent in cilia and flagella and is mostly found in cells that
possess these organelles (Bre´ et al., 1996; Levilliers et al., 1995).
Functional experiments on tubulin glycylation were difficult to
perform since the modifying enzymes were unknown. Initial
insights into the potential function of polyglycylation were ob-
tained using modification-specific antibodies. For example,
anti-glycylation antibodies affected axoneme beating in vitro,
suggesting that tubulin polyglycylation could regulate ciliary
dynein (Bre´ et al., 1996). In Tetrahymena, the elimination of the
major glycylation sites on b-tubulin was lethal or led to severe
axonemal defects, including short axoneme size, absence of the
central pair MTs, and incomplete outer doublet MTs (Redeker
et al., 2005; Thazhath et al., 2002; Xia et al., 2000). Thus, tubulin
glycylation could be an important regulator of both the assembly
and functions of axonemal MTs. The recent observations that
non-tubulin proteins are also substrates of polyglycylation
(Ikegami et al., 2008; Lalle et al., 2006; Xie et al., 2007) indicate
that glycylation is a posttranslational modification of general
importance.
Here we describe the discovery of a group of enzymes that
catalyze tubulin glycylation and show that some of these
enzymes have non-tubulin substrates. We demonstrate that gly-
cylases are members of the tubulin tyrosine ligase-like (TTLL)
family, which already contains three types of known amino
acid ligases, the tubulin tyrosine ligase (TTL; Ersfeld et al., 1993),
polyglutamylases (Janke et al., 2005; van Dijk et al., 2007; Wloga
et al., 2008), and an enzyme that ligates glycine to nucleosome
assembly protein 1 (NAP1; Ikegami et al., 2008). We show that
in mouse, TTLL3 and TTLL8 proteins are initiating glycylases
with different substrate specificities, whereas TTLL10 is the
elongating polyglycylase. In mammals, cooperation of these
two types of enzymes generates polyglycine side chains in
mammals, whereas inDrosophila, bifunctional enzymes catalyze
both reactions. We also demonstrate that the previously
reported absence of long glycine side chains on human sperm
tubulin (Bre´ et al., 1996) is caused by two inactivating amino
acid substitutions in human TTLL10. Finally, we show by RNA
interference (RNAi) that depletion of one of the two glycylases in
Drosophila leads to strong reduction in polyglycylation, which
causes defects in sperm maturation and results in male sterility.
Moreover, expression of interfering RNA under a stronger
promoter is lethal in early developmental stages. This suggests
that polyglycylation is important for whole organism develop-
ment in Drosophila. The identification of additional substrates
of glycylation indicates that this modification could have a broad
range of functions.
RESULTS
Identification of Murine Glycylases
Our study was initiated with the hypothesis that tubulin glycy-
lases, like two other types of tubulin amino acid ligases, TTL
(Ersfeld et al., 1993) and polyglutamylases (Janke et al., 2005;
van Dijk et al., 2007), are members of the TTLL protein family.
Within the mammalian TTLL family, TTLL3, 8, 10, and 12 re-
mained uncharacterized. According to phylogenetic studies,
the TTLL12 gene is present in species that appear to lack glycy-
lation (Janke et al., 2005; Schneider et al., 1997), and murine
TTLL12 has no glycylation activity in vivo and in vitro (K.R.,
unpublished data). In contrast, the presence of orthologs of
TTLL3, 8, and 10 in genomes of diverse species (Janke et al.,
2005) correlates with the known presence of tubulin glycylation,
and a recent study showed that one of these three genes,
TTLL10, encodes a glycylase for NAPs (Ikegami et al., 2008).
To test whether mouse TTLL3, 8, and 10 have a tubulin glycy-
lase activity, we expressed the respective cDNAs (van Dijk et al.,
2007) in HEK293 cells and tested the cell extracts in an in vitro
MT glycylation assay. To distinguish between two possible types
of activities, initiation (addition of the first glycine to a g-carboxyl
group of the target glutamate residue) and elongation of glycine
side chains, we used substrates differing in the levels of tubulin
glycylation: MTs polymerized from brain tubulin (that lack detect-
able glycylation) and strongly glycylated MTs of ciliary axonemes
of Tetrahymena thermophila. Both TTLL3 and 8 promoted incor-
poration of [3H]-glycine into brain MTs but had very low activity
on axonemal MTs. In contrast, TTLL10 was almost inactive on
brain MTs but promoted efficient [3H]-glycine incorporation
into axonemal MTs (Figure 1A). These observations suggest
that TTLL3 and 8 are initiating glycylases, whereas TTLL10 is
an elongating glycylase (polyglycylase) for tubulin. A similar func-
tional specialization has been previously observed among poly-
glutamylases (van Dijk et al., 2007; Wloga et al., 2008).
We also examined the selectivity of the enzymes for a- and
b-tubulin. TTLL3 and 8 modified both a- and b-tubulin of brain
MTs, with TTLL8 showing preference for a-tubulin (Figure 1A).
For TTLL10, which modified only axonemal MTs, two-dimen-
sional electrophoresis was used to separate axonemal a- and
b-tubulin. Using anti-a- or b-tubulin antibodies as well as
TAP952 (an antibody that recognizes monoglycylated sites on
tubulins; Bre´ et al., 1998), we found that both tubulin subunits of
Tetrahymena axonemes are monoglycylated and thus are poten-
tial substrates for the elongation reaction. However, TTLL10
incorporated [3H]-glycine mainly into a-tubulin (Figure 1B).
Next, we expressed TTLL3, 8, and 10 in U2OS cells and
labeled the cells with antibodies that are specific to eithermono- or polyglycylation: TAP952 and polyG (polyG specifically
recognizes polyglycine chains; Duan and Gorovsky, 2002),
respectively (Figure 1C). Nontransfected U2OS cells show no
reactivity with either of these two antibodies (arrowheads). After
expression of TTLL3 or 8, we detected specific labeling of MTs
with TAP952 but not with polyG. Thus, TTLL3 and 8 mediate initi-
ation of glycine side chains on MTs in vivo but not side chain
elongation. In contrast, cells expressing TTLL10 alone showed
no labeling with TAP952 but had a diffuse labeling with polyG
that did not correspond to MTs. This suggests that TTLL10
adds polyglycine chains directly onto proteins that are not asso-
ciated with MTs, while it cannot modify MTs without prior mono-
glycylation.
Two-Step Glycylation Mechanism in Mammals
To test whether the two types of mammalian glycylases can
function in a cooperative manner to create long side chains on
MTs, we co-overexpressed either TTLL3 or 8 together with
TTLL10 in U2OS cells. In both cases, we observed a strong
labeling of MTs with the polyG antibody (Figure 2A). These
results indicate that MTs have acquired polyglycine side chains,
which was not the case when TTLL3, 8, or TTLL10 were ex-
pressed alone (Figure 1C).
On immunoblots, the monoglycylation-specific antibody
TAP952 detected strong signals in the tubulin region upon
expression of TTLL3 or 8 alone. Additional protein bands were
labeled after TTLL8 expression, suggesting that TTLL8 can
mediate glycylation of other non-tubulin proteins (Figure 2B).
TTLL3 increased glycylation of mostly b-tubulin in U2OS cells,
while it promoted modification of both a- and b-tubulin in the
in vitro assay (Figures 2B and 1A). Thus, it appears that the
substrate preferences of the glycylating enzymes change de-
pending on additional factors. Neither TTLL3 nor TTLL8 alone
generated polyG-reactive epitopes, indicating that they are
indeed restricted to reactions that generate monoglycine side
chains (Figure 2B). In contrast, no TAP952 labeling was detected
in extracts of cells expressing TTLL10. However, a strong polyG
signal was induced on two distinct protein bands, one of them
the size of a-tubulin (Figure 2B). We demonstrate that the
substrate in the tubulin region corresponds to NAPs. First,
two-dimensional immunoblot analysis shows that the polyglycy-
lated 50 kDa protein band superimposes with NAPs but not with
tubulins (Figure 2C), and second, ectopically expressed NAP1-
EYFP and NAP2-EYFP were strongly polyglycylated by TTLL10
(Figure S1 available online). This is in agreement with the results
of Ikegami et al. (2008) and indicates that in contrast to tubulins,
NAPs can be polyglycylated directly by TTLL10.
After coexpression of TTLL3 or 8 with TTLL10, no TAP952
labeling was detected, whereas several protein bands were
labeled with the polyG antibody. Virtually all protein bands labeled
with TAP952 after expression of TTLL3 or 8 alone became labeled
with polyG when TTLL10 was coexpressed (Figure 2B), suggest-
ing that following monoglycylation by TTLL3 or 8, TTLL10 elon-
gates glycine side chains of all major substrates of the initiating
enzymes. The efficiency of this process is illustrated by the reduc-
tion of monoglycylated epitopes below detectable levels. This
further indicates that the substrate specificity of polyglycylation
in mammals is predetermined by the specificity of the initiatingCell 137, 1076–1087, June 12, 2009 ª2009 Elsevier Inc. 1077
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Figure 1. Enzymatic Characterization of Murine Glycylases
(A) In vitro glycylation activity of TTLL3, 8, and 10 using brain MTs that lack detectable glycylation and highly glycylated Tetrahymena axonemal MTs as
substrates. The incorporation of [3H]-glycine was separately determined for a- and b-tubulin for brain, but not for axonemal MTs due to comigration of both tubulin
subunits.
(B) Two-dimensional analysis of a- and b-tubulin from Tetrahymena ciliary axonemes (12G10: anti-a-tubulin; E7: anti-b-tubulin). While both tubulin subunits are
monoglycylated (TAP952 panel), the TTLL10-enriched fraction incorporates [3H]-glycine mainly into a-tubulin in vitro (autoradiography panel).
(C) Immunofluorescence analysis of U2OS cells overexpressing TTLL3-EYFP, TTLL8, or TTLL10-EYFP. TAP952 labels the MT cytoskeleton of cells expressing
TTLL3 or 8 but not TTLL10. PolyG antibody detects a diffuse staining after TTLL10 overexpression. Nontransfected cells, visualized by DAPI staining of the nuclei,
are labeled with neither TAP952 nor polyG (arrowheads). *TTLL8 was expressed as an untagged protein and detected with anti-TTLL8 antibody. Scale bar is
20 mm.glycylases rather than by the specificity of elongating enzymes,
except for proteins that are directly modified by TTLL10, such
as the NAPs.
Loss of Elongating Activity in Humans
Human sperm axonemes, unlike sperm axonemes of several
other mammalian species studied so far, have side chains
limited to monoglycylation (Bre´ et al., 1996). We confirmed this
by comparing the status of glycylation in protein extracts
prepared from mouse, rhesus monkey, and human sperm using
the TAP952 and the polyG antibody (Figure 3A). Several mouse
and rhesus protein bands were strongly labeled with polyG,
while only weak signals were detected with TAP952. In contrast,
human sperm proteins were not labeled with polyG but strongly
with TAP952. No differences between the three species were1078 Cell 137, 1076–1087, June 12, 2009 ª2009 Elsevier Inc.found for the related tubulin modification, polyglutamylation
(Figure 3A, panel polyE).
To determine the molecular basis for the lack of elongated
polyglycine chains in human sperm, we investigated the only
known elongating glycylase in mammals, TTLL10. First, we con-
firmed the presence of a full-length mRNA by cloning TTLL10
from human testes cDNA. We then expressed human, mouse,
and rhesus TTLL10 in U2OS cells. The mouse and rhesus
TTLL10 generated polyglycylation that could be specifically
detected with polyG, whereas the human protein was inactive
(Figure 3B). Accordingly, when cell extracts from HEK293 cells
overexpressing the respective TTLL10 proteins were used for
in vitro assays, only the mouse and rhesus, but not the human,
TTLL10 mediated incorporation of [3H]-glycine into axonemal
MTs (Figure 3C). Domain-swapping experiments localized the
inactivating mutations to the central region of human TTLL10,
which corresponds to the highly conserved core TTL domain
(Figures S3, S4A, and S4B; van Dijk et al., 2007). Within this
domain, human and rhesus TTLL10 differ by 11 amino acids,
out of which 4 are not evolutionarily conserved. Thus, we
analyzed the remaining 7 amino acid changes by introducing




Figure 2. The Cooperative Mechanism of Murine Glycylases
(A) Immunofluorescence of U2OS cells coexpressing TTLL10-ECFP together
with TTLL3-EYFP or TTLL8-EYFP. Note that polyG antibody labels the cyto-
skeleton. Scale bar is 20 mm.
(B) Immunoblot analysis of extracts from U2OS cells expressing TTLL3-EYFP,
TTLL8, and TTLL10-6HA alone as well as TTLL3-EYFP or TTLL8 in combina-
tion with TTLL10-6HA. TAP952 recognizes protein bands exclusively in cell
extracts after expression of TTLL3 or 8. Different proteins are detected with
polyG antibody after overexpression of TTLL10 alone or in combination with
TTLL3 or 8.
(C) Two-dimensional electrophoresis and immunoblot of extracts from control
U2OS cells () or cells expressing TTLL10-6HA (+). The positions of a- and
b-tubulin as well as NAPs are determined with specific antibodies. (# polygly-
cylated NAPs; * nonspecific polyG signal).led to a complete loss of polyglycylase activity (Figures S3 and
S4C), suggesting that the corresponding amino acids are essen-
tial for activity. When these two mutations in human TTLL10 were
both reverted to the conserved amino acids found in rhesus and
mouse, the enzyme recovered polyglycylase activity (Figures 3D
and 3E). This was not the case if only one mutation was reverted.
As neither of the two mutations has been found in the genomes
of the great apes (not shown), it appears that humans are unique
in having lost the polyglycylation activity of TTLL10. One of the
two inactivating mutations (mut3) is polymorphic in the human
population, leading to a high incidence (55.0% heterozygote and
16.7% homozygote) of TTLL10 alleles without mut3 in the sub-
Saharan African population, whereas 91.7% of the European
population are homozygous for the presence of mut3 (http://
www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1320571). No poly-
morphism was found for mut5. To investigate if the mut3 poly-
morphism could affect the enzymatic activity of TTLL10, we
compared polyglycylation of sperm proteins from two homozy-
gote individuals either with or without mut3 but both bearing
mut5 (Figure S5A). The complete absence of polyglycylation on
sperm proteins from both individuals (Figure S5B) confirmed
that the presence of one of the two inactivating mutations is
sufficient for the complete loss of enzymatic activity of human
TTLL10 (Figure S4C).
In conclusion, we show that the human elongating glycylase
TTLL10 is functionally inactive due to two mutations, resulting
in the absence of polyglycylation in sperm. Considering that all
known amino acid ligases that modify tubulin are members of
the TTLL family, and that all TTLLs are expressed in testes (Ers-
feld et al., 1993; van Dijk et al., 2007), it is likely that TTLL10 is the
only polyglycylating enzyme in mammals. Thus, humans could be
a unique mammalian species that lacks protein polyglycylation.
Cancer-Associated Mutations Inactivate
the TTLL3 Enzyme
In a recently published screen for putative cancer-associated
genes, TTLL3 obtained a relatively high score as a potential
cancer gene (Sjo¨blom et al., 2006). It was striking that the two
mutations identified in the screen were localized in the vicinity
of the ATP-binding residue E662, which is essential for enzy-
matic activity in all TTLLs (Figure 4A; van Dijk et al., 2007). To
test the potential impact of these mutations, we introduced
them separately into mouse TTLL3, which is identical to human
TTLL3 in this region (Figure 4A), and tested the enzymatic activity
of the mutated enzymes. Each cancer-related mutation led to
a complete loss of glycylase activity of TTLL3 in vivo and
in vitro (Figures 4B–4D), suggesting that reduction of monoglycy-
lating activity could be related to cancer.
A Divergent Polyglycylation Mechanism in Drosophila
In mammals, TTLL10 appears to be the only enzyme able to
elongate glycine side chains. However, in Drosophila, an
organism with polyglycylated MTs (Bre´ et al., 1996), only two or-
thologs of the TTLL3/8 group are present, whereas no TTLL10
gene has been found (Janke et al., 2005). To establish the enzy-
matic mechanism that leads to the elongation of glycine side
chains in the absence of TTLL10, we investigated the activity





Figure 3. Evolutionary Loss of Polyglycylation in Humans
(A) Immunoblot analysis of mouse, rhesus, and human sperm proteins. The
polyG antibody detects specific protein bands in mouse and rhesus, but not
in human sperm. In contrast, TAP952 detects tubulin bands at a low level in
mouse and rhesus but strongly in human. The polyE antibody labels tubulin
of all three species equally strong.
(B) Immunoblot analysis of extracts from U2OS cells expressing mouse, rhe-
sus, or human TTLL10.
(C) In vitro enzymatic assay of mouse, rhesus, and human TTLL10 expressed in
HEK293 cells with axonemal MTs as a substrate.1080 Cell 137, 1076–1087, June 12, 2009 ª2009 Elsevier Inc.(CG11323) and dmTTLL3B (CG11201) in U2OS cells. Both
enzymes induced monoglycylation on MTs (Figure 5A, panel
TAP952). Some cells expressing dmTTLL3B showed a restricted
localization of this enzyme to the nucleus, and accordingly, only
the nucleus was labeled with TAP952 in those cells (Figure 5A, #).
However, in contrast to the mammalian orthologs (Figure 1C),
dmTTLL3A also generated polyglycylated MTs as detected
with polyG, while dmTTLL3B polyglycylated nuclear proteins
but not MTs (Figure 5A, panel polyG). Immunoblots revealed
that dmTTLL3A initiates and elongates glycine side chains on
a- and b-tubulin, whereas dmTTLL3B initiates glycylation on a
number of proteins including a-tubulin but functions as an elon-
gating glycylase only for non-tubulin substrates (Figure 5B).
These polyglycylated substrates of yet unknown identity are
likely to be responsible for the observed nuclear staining (Fig-
ure 5A). Thus, Drosophila has a polyglycylation mechanism that
utilizes bifunctional initiating/elongating glycylases.
dmTTLL3B Is Essential in Drosophila
Polyglycylation is particularly abundant in testes where it is asso-
ciated with the axonemes of the sperm flagella (Bre´ et al., 1996;
Bressac et al., 1995). In Drosophila, one of the polyglycylase
genes, dmTTLL3B, is highly expressed in testes (Figure S6), sug-
gesting that dmTTLL3B is the major polyglycylase in this organ.
Thus, we attempted to deplete dmTTLL3B by RNAi, using a trans-
genic fly carrying inverted repeats that correspond to dmTTLL3B
under the control of UAS sequences inducible by Gal4 (UAS-
IR-dmTTLL3B transgene). Strikingly, 50% of the embryos
carrying UAS-IR-dmTTLL3B and the ubiquitous da-Gal4 driver
(dmTTLL3Bda-RNAi) did not survive to adulthood (Figure 6A).
RT-PCR analysis of adult dmTTLL3Bda-RNAi flies demon-
strated that dmTTLL3B inverted repeats were expressed and
dmTTLL3B mRNA levels were strongly decreased. In contrast,
mRNA levels of the closest homolog of this gene, dmTTLL3A,
were unchanged (Figure 6B), demonstrating the specificity of
the dmTTLL3B RNAi. Immunoblots of whole-protein extracts
showed a strong reduction of polyG labeling on a range of
protein bands in the dmTTLL3Bda-RNAi flies (Figure 6C), whereas
polyglutamylation levels were slightly increased in males but not
in females (Figure 6C, panel GT335). These data provide strong
evidence that the majority of the protein polyglycylation in
Drosophila is catalyzed by dmTTLL3B. Almost all adult male
dmTTLL3Bda-RNAi flies were sterile, as only 2.4% were able to
generate offspring (Figure 6D), although with 20 times less
progeny as compared to wild-type. This suggests that polygly-
cylation is important for spermatogenesis.
(D) Immunoblot of U2OS cells expressing wild-type rhesus and human
TTLL10, as well as human TTLL10 containing sequence reversions to amino
acids present in rhesus and mouse TTLL10 (see Figure S3): S 448 N (rev3;
reversion of mut3; see Figure S4C), K 467 T (rev5; reversion of mut5; see
Figure S4C), or both of them (rev3+5). Wild-type rhesus TTLL10 and human
TTLL10 carrying both rev3 and rev5 generated a strong polyG signal on
NAPs, indicative of polyglycylase activity.
(E) Schematic representation of the human TTLL10 protein indicating the local-
ization of the two amino acid reversions that allowed for reactivation of polygly-
cylase activity. The localization of the conserved core TTL domain (yellow) and




Figure 4. Loss of Enzymatic Activity of TTLL3 in Colon Cancer
(A) Sequence alignment of different TTLL proteins from different organisms
maps the position of two cancer-related mutations in TTLL3 (G647S: green,
M669I: pink; Sjo¨blom et al., 2006) to two highly conserved residues in the
vicinity of the conserved ATP-binding site (E662: yellow). Amino acids in red
letters: identity; in blue: similarity.The process of spermatogenesis in Drosophila can be divided
into three major steps: (1) the generation of 64 haploid, intercon-
nected spermatocytes from a stem cell, (2) the formation of the
axonemes and the condensation of the sperm nuclei in the still
interconnected spermatids, and (3) the individualization that
resolves the syncytial sperm bundle into 64 separate sperm
cells. This last step is achieved by a group of synchronously
moving individualization complexes that remove excess cyto-
plasm and place the membranes around each cell. To determine
which of the three steps were affected in dmTTLL3Bda-RNAi flies,
we analyzed the testes by immunofluorescence and transmis-
sion electron microscopy (TEM). In immunofluorescence (Fig-
ure 6E) of wild-type testes, the polyG antibody stained prominent
bundles of fibers that correspond to the sperm tails. The actin
staining visualized groups of regularly arranged individualization
complexes, which were always associated with the polyG-reac-
tive MT bundles, confirming that sperm polyglycylation appears
at the onset of individualization (Bre´ et al., 1996; Bressac et al.,
1995). In contrast, in dmTTLL3Bda-RNAi testes, polyG staining
was strongly reduced and actin cones were scattered along
the tails, indicating a sperm individualization defect (Fabrizio
et al., 1998). Moreover, we observe that the tips of the testes
were often enlarged in dmTTLL3Bda-RNAi male flies (Figure 6E).
To better understand the observed defects, we used TEM to
compare cross-sections of sperm cysts at different stages of
maturity. In the preindividualization stage, sperm cysts of both
control and dmTTLL3Bda-RNAi flies appeared similar, as they
contained the expected 64 sperm cells with an axoneme as
well as a minor and a major mitochondrial derivate (Figure 6F).
Upon maturation, sperm cysts become more compact due to
strongly reduced cytoplasmic ground substance. At this late
stage, control cysts were highly organized as each axoneme
was positioned in the close proximity of a major mitochondrial
derivate (Figure 6G, panel control). In contrast, most of the
mature cysts from dmTTLL3Bda-RNAi flies were lacking the
axoneme structures, whereas the mitochondrial derivates were
still present (Figure 6G, panels dmTTLL3Bda-RNAi). In some
cases, disorganized axonemes composed of singlet MTs were
found. We also observed rare cases of disorganized cysts that
still contained axonemes but had reduced or absent mitochon-
dria. Together our findings indicate that polyglycylation plays
a role in individualization and is essential for the maintenance
of the axoneme structure at later stages. However, it is not
required for the early steps of Drosophila spermatogenesis,
including the assembly of the axonemes.
Finally, we hypothesized that the initially observed partial
lethality of the dmTTLL3Bda-RNAi flies indicates an essential func-
tion of dmTTLL3B in Drosophila, and that the flies that reached
adulthood survived due to the incomplete suppression of
dmTTLL3B under the da-Gal4 driver. To test this hypothesis, we
increased the efficiency of the RNAi by introducing theUAS-Dcr-2
(B) TAP952 labeling of U2OS cells expressing wild-type TTLL3-EYFP and the
mutated proteins including the E662G ATPase dead version. Scale bar is 20 mm.
(C) Immunoblot of extracts from U2OS cells expressing wild-type and mutated
TTLL3s.
(D) In vitro glycylation assay of extracts from HEK293 cells expressing either the
wild-type or mutated forms of TTLL3, using brain MTs as substrate.Cell 137, 1076–1087, June 12, 2009 ª2009 Elsevier Inc. 1081
transgene (Dietzl et al., 2007) into thedmTTLL3Bda-RNAi flies. Strik-
ingly, we observed 100% lethality at the larval stage. This pheno-
type is not due to side effects of the UAS-Dcr-2 transgene (Dietzl
et al., 2007) since the expression ofUAS-IR-dmTTLL3B under the
control of the very strong and ubiquitous Act5C-Gal4 driver also
led to 100% lethality (not shown). Thus, in addition to an important
role in spermatogenesis, dmTTLL3B-mediated polyglycylation
could be essential for Drosophila development.
A B
Figure 5. The Enzymatic Mechanism of Polyglycylation in
Drosophila
(A) Immunofluorescence analysis of U2OS cells expressing Drosophila mela-
nogaster (dm) TTLL3A-EYFP and TTLL3B-EYFP proteins. TAP952 labels cyto-
skeletal structures in cells expressing either of these proteins; however, some
cells with a dominant nuclear localization of dmTTLL3B (#) show only diffuse
nuclear labeling with this antibody. PolyG decorates the cytoskeleton in cells
expressing dmTTLL3A but only the nucleus in the cells that express
dmTTLL3B. Nontransfected cells are visualized by DAPI staining of the nuclei.
Scale bar is 20 mm.
(B) Immunoblot analysis of extracts from U2OS cells expressing dmTTLL3A
and dmTTLL3B. Both enzymes generate specific labeling of protein bands
with the TAP952 and polyG antibodies. (* nonspecific polyG signal)1082 Cell 137, 1076–1087, June 12, 2009 ª2009 Elsevier Inc.Identification of Candidate Substrates of Glycylation
The observation that mouse TTLL8 as well asDrosophila TTLL3B
glycylate a range of non-tubulin proteins (Figures 2B, 5B, and 6C)
raised the possibility that glycylation is a posttranslational modi-
fication with a broad range of substrates. Following the observa-
tion that the two most prominent substrates of polyglutamyla-
tion, tubulins (Edde´ et al., 1990) and NAPs (Regnard et al.,
2000), are also modified by polyglycylation (Redeker et al.,
1994; Ikegami et al., 2008), we hypothesized that additional
substrates of glycylation are among the previously identified
substrates of polyglutamylation (van Dijk et al., 2008). We ex-
pressed 12 potential substrates of polyglutamylation together
with either TTLL8 or an enzymatically inactive (dead) version of
TTLL8 in HEK293 cells. Five proteins (ANP32A, ANP32B, SET,
RanGAP, and nucleolin) were found to be glycylated in the pre-
sence of active but not inactive TTLL8 (Figure 7). Seven other
proteins tested (NF45, B23, GRP78, NASP, RNP-K, NCT, EB1;
data not shown) were not modified. To uncover additional
substrates by a more direct approach, we separated proteins
from fly testes using two-dimensional electrophoresis and
analyzed polyG-reactive proteins by mass spectrometry. We
selected six of the identified proteins (Table S1; see Supple-
mental Data for more details) and co-overexpressed them with
active or inactive TTLL8 in HEK293 cells. Among these proteins,
troponin T was found to be specifically glycylated by ectopic
TTLL8 (Figure 7). The identification of a range of potential
substrates of glycylation suggests that this modification could
regulate the function of many proteins. Thus, the lack of glycyla-
tion of several proteins, and not only tubulin, could have con-
tributed to the defects observed in the dmTTLL3B-depleted
flies.
DISCUSSION
Polyglycylation was first described as a polymodification that
generates glycine side chains of variable lengths on a- and
b-tubulins (Redeker et al., 1994). Similarly to polyglutamylation,
it targets the C-terminal tails of tubulins, which are the major
interaction sites for MT-associated proteins and molecular
motors (Nogales, 2000). Thus, polyglycylation could be an
important regulator of MT functions.
We have identified a group of enzymes that mediate the gener-
ation of glycine side chains on proteins. The glycylating enzymes
are members of the TTLL family, which also contains other
enzymes that catalyze amino acid ligations: tubulin tyrosine
ligase (Ersfeld et al., 1993) and diverse polyglutamylases (Janke
et al., 2005; van Dijk et al., 2007; Wloga et al., 2008). Initiation and
elongation of the glycine side chains are catalyzed by separate
glycylases in mammals. Two initiating enzymes, TTLL3 and
TTLL8, both generate monoglycylation on tubulin, whereas
only TTLL8 modifies additional proteins. In agreement with our
results, TTLL3 proteins in the ciliate Tetrahymena and in zebra-
fish are also initiating tubulin glycylases (Wloga et al., 2009).
The subsequent elongation of glycine side chains in mammals
is catalyzed by the elongating glycylase TTLL10.
The discovery of a strict two-step mechanism for MT polygly-
cylation in vertebrates raised two questions related to previous
descriptions of polyglycylation patterns in different organisms.
First, elongated glycine side chains are completely absent in
human sperm tubulin (Bre´ et al., 1996). We show that this pheno-
type is directly related to human TTLL10, which lacks enzymatic
activity due to two point mutations in the conserved core TTL
domain. It is striking that these mutations appear to be unique
to human TTLL10, which suggests that the loss of polyglycyla-
tion was an event important for human evolution. Furthermore,
the existence of a species devoid of polyglycylation suggests
that the ‘‘poly’’ character of glycylation is not essential for protein
functions, and that the functions of glycylation could be effi-
ciently fulfilled by monoglycylation, which is present in all cilia
in mammals (Dossou et al., 2007). Another surprising observa-
tion was that Drosophila, an organism with reported polyglycine
side chains on tubulin (Bre´ et al., 1996), has no homologs of
TTLL10. We show that in Drosophila, glycylases from the
TTLL3/8 group act as bifunctional enzymes that are able to cata-
lyze both initiation and elongation of glycine side chains, explain-
ing why polyglycine side chains are present despite the absence
of a TTLL10 ortholog. The two distinct glycylation mechanisms
in mammals and Drosophila correlate with the previously
described order of appearance of polyglycylation during sperm
maturation. In mouse, polyglycine side chain elongation is de-
layed, appearing only after initial monoglycylation (Kann et al.,
1998), whereas in Drosophila, mono- and polyglycylation occur
simultaneously (Bre´ et al., 1996).
InDrosophila the depletion of dmTTLL3B induced a significant
decrease in glycylation, accompanied by decreased viability and
an almost complete sterility of the surviving males. Detailed anal-
ysis of the dmTTLL3Bda-RNAi flies revealed that the lack of
dmTTLL3B affects late stages of spermatogenesis. This coin-
cides with the timing of appearance of glycylation in Drosophila
sperm development (Bressac et al., 1995). We observed that
although axonemes assemble, they become unstable and disas-
semble in the final stages of spermatogenesis. The disassembly
of the axonemes is likely to proceed through a stage in which MT
doublets are reduced to singlets, followed by the complete
disappearance of all MT structures. Thus, one of the roles of gly-
cylation in spermatogenesis appears to be the maintenance of
the axonemal structure, whereas the modification is not required
for the assembly.
Due to their sensory role in cells, cilia are centers of signal
transduction pathways involved in embryonic development
and tissue homeostasis in adults. Therefore, defects in cilia
can be related to cancer (Mans et al., 2008; Michaud and Yoder,
2006). Our finding that two cancer-related mutations in TTLL3
(identified by Sjo¨blom et al., 2006) both completely inactivate
this enzyme suggests that the lack of TTLL3 activity could affect
cilia, which in turn could contribute to cancer progression.
The complexity of signals generated by polyglutamylation and
polyglycylation on MTs could allow for different modes of regu-
lation. Besides the possibility that both polymodifications
generate signals for different target proteins, glycylation could
also function as a counter-regulator of polyglutamylation, since
both modifications compete for similar modification sites on
tubulin (Redeker et al., 2005). In agreement with this hypothesis,
we show that tubulin polyglutamylation increases upon depletion
of polyglycylation. Such a function could be sufficiently fulfilled
by monoglycylation, which would help to explain the apparentlack of phenotypes related to the loss of elongated glycine side
chains in humans.
Most of the past work on glycylation has been focused on the
role of this modification in MT functions; however, several recent
studies have shown that other proteins are substrates of glycyla-
tion (Ikegami et al., 2008; Lalle et al., 2006; Xie et al., 2007).
Together with our results, this opens the possibility that glycyla-
tion targets a broad range of substrates.
To conclude, we have identified a group of tubulin-modifying
enzymes and two evolutionarily divergent mechanisms for
glycine side chain initiation and elongation. Functional studies
in Drosophila show that glycylation is important for sperm matu-
ration, and that it might also be essential in early developmental
stages in flies. Finally, the discovery that several important
proteins could undergo glycylation raises the possibility that
this modification acts as a general regulator of cellular functions.
EXPERIMENTAL PROCEDURES
Cloning and Mutagenesis
Mouse TTLL3, 8, and 10 have been identified and cloned before (van Dijk et al.,
2007). The rhesus monkey (Macaca mulatta) TTLL10 cDNA sequence was re-
constructed from fragments found by NCBI Blast (http://blast.ncbi.nlm.nih.
gov/) using known TTLL10 sequences as templates. The predicted sequence
was amplified from testis cDNA (BioChain Institute Inc., USA) and cloned,
and the DNA was sequenced. PCR-related mutations were excluded by
sequencing of multiple clones (complete coding sequence: Figure S2A). For
human TTLL10, a splice variant (Figure S2C) of the sequence AK124125 has
been amplified from testis cDNA (BioChain Institute Inc.) and verified by
DNA sequencing. Drosophila dmTTLL3A (CG11323) and dmTTLL3B
(CG11201) were cloned from cDNA from adult flies.
Point mutations were introduced by a PCR-based quick-change method.
The presence of the mutation was verified by DNA sequencing.
Drosophila Genetics
Drosophila was grown on standard medium at 25C. The w1118, UAS-IR-
TTLL3B transgenic line was obtained from the Vienna Drosophila RNAi Center
(http://www.vdrc.at). The transgene, localized on the X chromosome,
expresses an inverted repeat from the dmTTLL3B gene (CG11201) under
the control of UAS sequences.UAS-IR-TTLL3B flies were crossed with strains
carrying the da-Gal4 (dmTTLL3Bda-RNAi) or the Act5C-Gal4 driver. For amplifi-
cation of the RNAi effect, the da-Gal4 transgene was associated with theUAS-
Dcr-2 transgene (Dietzl et al., 2007), and the resulting strain was crossed with
UAS-IR-TTLL3B flies. For the viability test, 352 control (UAS-IR-TTLL3B) and
510 dmTTLL3Bda-RNAi embryos were scored for survival to adulthood (results
represented in Figure 6A). Total RNA was extracted from adult flies with TRI-
ZOL reagent (Sigma, USA), and reverse transcription was performed using
the First-Strand cDNA synthesis kit (GE Healthcare, USA) with 5 mg of RNA
and random hexamers as primers. 1/60 of this cDNA was used for PCR ampli-
fication. Primer pairs used for the detection of different gene transcripts can be
provided on request. Number of PCR cycles used for RT-PCR: RNAi,
dmTTLL3B: 30, dmTTLL3A: 35, rp49: 25. Male fertility was tested in individual
crosses with w1118 females, and the presence of progeny was scored after
2 weeks. Fifty-five individual crosses were scored for control (UAS-IR-TTLL3B)
and 83 for dmTTLL3Bda-RNAi males (results represented in Figure 6D).
Isolation of Axonemes from Tetrahymena Cilia
CU427 Tetrahymena cells were grown in SPP medium (1% proteose peptone,
0.2% glucose, 0.1% yeast extract, 0.003% EDTA ferric sodium salt) at 30C to
mid-log phase (4–5 3 105 cells/ml). Cilia were collected as described (Brown
et al., 1999) and stored at80C. For thepreparation of axonemes, cilia were de-
membranatedusing 0.2% NP-40 in13ERB buffer (50mM Tris/HCl, pH 8.0, 10%






Figure 6. Effects of dmTTLL3B Depletion in Drosophila
(A) Comparison of the survival of female and male flies carrying UAS-IR-dmTTLL3B transgene in the presence or absence of the driver. The percentage of viable
adult flies as compared to the number of embryos is shown.
(B) RT-PCR analysis of dmTTLL3B-RNAi, dmTTLL3B, dmTTLL3A, and rp49 expression in control (da-Gal4/+) and dmTTLL3Bda-RNAi flies.
(C) Immunoblots of whole-fly extracts, probed for polyglycylation (polyG), polyglutamylation (GT335), and a-tubulin (12G10). In control (da-Gal4/+) flies, multiple
proteins are labeled with polyG antibody in male and female flies. This labeling is strongly reduced in dmTTLL3Bda-RNAi flies. In contrast, polyglutamylation is only
detected in male individuals and increases upon depletion of polyglycylation.
(D) Sterility of male flies carrying UAS-IR-dmTTLL3B transgene in the presence or absence of the driver.
(E) Immunofluorescence of testes from control (da-Gal4/+) and dmTTLL3Bda-RNAi flies. Actin is stained with TRITC-conjugated phalloidin (red), and polyglycylated
proteins are revealed with polyG antibody (green). Nuclei are stained with DAPI (blue). In dmTTLL3Bda-RNAi flies, polyglycylation levels are decreased and actin
cones are scattered. The tip of the testes (arrowhead) is enlarged. Insets show the distribution of actin cones (zoom 2.53). Scale bar is 100 mm.1084 Cell 137, 1076–1087, June 12, 2009 ª2009 Elsevier Inc.
activity, axonemes were further treated with 1 M NaCl in 13 ERB for 30 min, fol-
lowed byan incubation at60C for20min. Axonemes were spun down (12,000 g,
30 min, 4C), and the supernatant was discarded. The pellet was then washed in
13 ERB and resuspended in 13 ERB at a final concentration of 5 mg/ml.
Tubulin Polyglycylation Assay
The enzymatic activity of glycylase was determined based on incorporation of
[3H]-glycine into MTs. The assay was performed in 50 ml of 13 ERB supple-
mented with 2 mM ATP and 250 pmol (5 ml) [3H]-glycine (20.0 Ci/mmol; GE
Healthcare). Enzymatic activity was measured using cell extracts prepared
in 13 ERB containing 0.2% NP-40. Twenty micrograms of axonemal or taxo-
tere-stabilized MTs (prepared from adult mouse brains as described; Regnard
et al., 1999) were resuspended in the reaction mixture and immediately trans-
ferred to 30C, followed by 4 hr of incubation. The samples were then sub-
jected to SDS-PAGE (10% gels) and electrotransferred onto nitrocellulose
membrane. The tubulin bands were visualized by staining with Ponceau S,
cut out, and placed in 5 ml of scintillation liquid (Ultima Gold, Perkin Elmer,
USA) for quantification. Alternatively, SDS-PAGE gels were stained with Coo-
massie blue and incubated in Amersham Amplify (GE Healthcare), and [3H]-
glycine incorporation was visualized by autoradiography. Absolute values
can vary between enzymatic tests. Values shown in Figures 1A, 3C, and 4D
are representative for multiple experiments.
Affinity Purification of EYFP-Tagged Proteins
EYFP-tagged potential substrates were coexpressed with TTLL8 in HEK293
cells. After lyses of the cells in PBS, 0.2% NP-40, the supernatant (100,000 g,
30 min, 4C) was incubated with GFP-TRAP agarose beads (ChromoTek,
Germany) for 4 hr at 4C. Beads were washed twice in PBS, 0.2% NP-40 and
boiled in Laemmli sample buffer for 5 min. The samples were spun at 20,000 g
for 5 min and supernatants were analyzed by SDS-PAGE and immunoblot.
Protein Electrophoresis and Immunoblot
One-dimensional SDS-PAGE was performed using standard protocols, or
a special protocol for the separation of mammalian a- and b-tubulin (Edde´
et al., 1987). Two-dimensional electrophoresis consisted of an isolelectric
focusing step (IPGphor Isoelectric Focusing System; GE Healthcare) and an
SDS-PAGE. For the resolution of the tubulin in Figure 1B, 40 mg of tubulin were
loaded on 18 cm pH 4.5–5.5 Immobiline strips (GE Healthcare). Cell extracts
shown in Figure 2C were prepared directly in the loading buffer (7 M urea, 2 M
thiourea, 4% [w/v] CHAPS, 2% [v/v] IPG buffer [GE Healthcare], 40 mM DTT)
and resolved in 8.5 cm pH 3.0–5.6 Immobiline strips (GE Healthcare).
Membranes were incubated with the following antibodies: polyG (1:6000),
polyE (1:1000; both courtesy of M. Gorovsky), TAP952 (Bre´ et al., 1998; ascitic
Figure 7. Substrates of Glycylation
EYFP-tagged mouse or Drosophila proteins were coexpressed with
active (A) or inactive (‘‘dead’’; D) mouse TTLL8 in HEK293 cells. After
EYFP affinity purification, proteins were detected with anti-GFP anti-
body, and the level of glycylation was determined with TAP952. The
total extract was probed for TTLL8 expression with anti-TTLL8
antibody.
fluid, 1:2000), 12G10 (Thazhath et al., 2002; 1:250), E7 (Chu and Klym-
kowsky, 1989; 1:20), 12CA5 (1:10), anti-GFP (1:5000; Torrey Pines
Biolabs, USA), anti-NAP 4A8 (Fujii-Nakata et al., 1992; Ishimi et al.,
1985; 1:20). Antibodies against TTLL8 were raised in rabbits with
bacterially expressed protein and then purified on recombinant
TTLL8 and used at 1:500 dilution.
Protein bands were visualized with HRP-labeled donkey anti-rabbit or anti-
mouse IgG 1:10,000 (GE Healthcare) followed by detection with ECL immuno-
blot detection kit (GE Healthcare).
Immunofluorescence and Microscopy
U2OS cells were cultured on glass coverslips under standard conditions and
fixed using a protocol for preservation of cytoskeletal structures (Bell and
Safiejko-Mroczka, 1995). Fixed cells were incubated with TAP952 (hybridoma
supernatant 1:200), polyG (1:3000), anti-TTLL8 (1:1000), or anti-GST (1:1000)
antibody for 1 hr, followed by 30 min with anti-mouse or anti-rabbit Alexa 555
or Alexa 488 antibody (1:1000; Molecular Probes, USA). DNA was visualized by
DAPI staining (0.02 mg/ml). Coverslips were mounted with MOWIOL. Drosophila
testes were fixed for 30 min with 3.7% paraformaldehyde in PBS, permeabilized
in PBS containing 0.5% Triton X-100, and incubated with polyG (1:9000) for 1 hr,
followed by 30 min with anti-rabbit Alexa 647. Actin was visualized with TRITC-
conjugated phalloidin (1:10,000; Sigma). We used DMRA microscopes (Leica,
Germany) and Metamorph (Universal Imaging Corp., USA) software.
For ultrastructural analysis, testes were isolated from 3- to 4-day-old male
flies and fixed in 3.5% glutaraldehyde in 100 mM phosphate buffer (pH 7.4)
overnight at 4C. The samples were rinsed in phosphate buffer and post-fixed
in 1% osmic and 0.8% potassium ferrocyanide for 2 hr in the dark at room
temperature (RT). After rinsing in phosphate buffer, samples were dehydrated
in a series of ethanol solutions (30%–100%) and embedded in EmBed 812
DER 736. Eighty-five nanometer sections were cut on a Leica-Reichert
Ultracut E microtome and counterstained with uranyl acetate and lead citrate.
Images were acquired with a Hitachi 7100 transmission electron microscope
at the Centre de Ressources en Imagerie Cellulaire de Montpellier (France).
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